Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.

about

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza.

P2860

Q30151807-AC0CFFF4-CB8B-4D6C-81DF-75BA8FE008B3 Q47125913-B7ACCEA6-691E-4513-A247-F09A0E468879

P2860

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.

Item

http://www.wikidata.org/entity/Q36637886

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Implementation of new approach ...... Russian master donor viruses.

@ast

Implementation of new approach ...... Russian master donor viruses.

@en

type

Item

label

Implementation of new approach ...... Russian master donor viruses.

@ast

Implementation of new approach ...... Russian master donor viruses.

@en

prefLabel

Implementation of new approach ...... Russian master donor viruses.

@ast

Implementation of new approach ...... Russian master donor viruses.

@en

P1476

Implementation of new approach ...... Russian master donor viruses.

@en

P2093

Natalie Larionova

http://www.w3.org/2001/XMLSchema#string

Nicholas Pearce

http://www.w3.org/2001/XMLSchema#string

Svetlana Shcherbik

http://www.w3.org/2001/XMLSchema#string

Tatiana Bousse

http://www.w3.org/2001/XMLSchema#string

Xiyan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses.

[Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells]

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Cross-protective immunity to influenza A viruses.

[Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].

PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries.

The development of live attenuated cold-adapted influenza virus vaccine for humans.

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.

P304

33-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVIROMET.2015.10.009

http://www.w3.org/2001/XMLSchema#string

P478

227

http://www.w3.org/2001/XMLSchema#string

P50

David E. Wentworth

Larisa Rudenko

Irina Kiseleva

P577

2015-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283444202

http://www.w3.org/2001/XMLSchema#string

P698

26519883

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

4773654

http://www.w3.org/2001/XMLSchema#string

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.

about

P2860

P2860

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932